179 related articles for article (PubMed ID: 36399467)
1. KCNQ1OT1 sponges miR-34a to promote malignant progression of malignant melanoma via upregulation of the STAT3/PD-L1 axis.
Wang X; Ren Z; Xu Y; Gao X; Huang H; Zhu F
Environ Toxicol; 2023 Feb; 38(2):368-380. PubMed ID: 36399467
[TBL] [Abstract][Full Text] [Related]
2. LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1.
Chen QH; Li B; Liu DG; Zhang B; Yang X; Tu YL
Cancer Cell Int; 2020; 20():394. PubMed ID: 32821247
[TBL] [Abstract][Full Text] [Related]
3. KCNQ1OT1 affects cell proliferation, invasion, and migration through a miR-34a / Notch3 axis in breast cancer.
Ren Z; Xu Y; Wang X; Ren M
Environ Sci Pollut Res Int; 2022 Apr; 29(19):28480-28494. PubMed ID: 34993814
[TBL] [Abstract][Full Text] [Related]
4. lncRNA MIAT targets miR-411-5p/STAT3/PD-L1 axis mediating hepatocellular carcinoma immune response.
Zhang X; Pan B; Qiu J; Ke X; Shen S; Wang X; Tang N
Int J Exp Pathol; 2022 Jun; 103(3):102-111. PubMed ID: 35429078
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
Wang QM; Lian GY; Song Y; Huang YF; Gong Y
Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA Opa interacting protein 5-antisense RNA 1 binds to micorRNA-34a to upregulate oncogenic PD-L1 in non-small cell lung cancer.
Qiao X; Zhao F
Bioengineered; 2022 Apr; 13(4):9264-9273. PubMed ID: 35411833
[TBL] [Abstract][Full Text] [Related]
7. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
8. STAT3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p/GOLM1 axis.
Bai M; Wu ZZ; Huang YL; Ke J; Xu Q; Wang X
J Gene Med; 2021 Jul; 23(7):e3338. PubMed ID: 33822440
[TBL] [Abstract][Full Text] [Related]
9. XIST/miR-34a-5p/PDL1 axis regulated the development of lung cancer cells and the immune function of CD8
Li J; Che L; Xu C; Lu D; Xu Y; Liu M; Chai W
J Recept Signal Transduct Res; 2022 Oct; 42(5):469-478. PubMed ID: 35067156
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
Roshani Asl E; Rasmi Y; Baradaran B
J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473
[TBL] [Abstract][Full Text] [Related]
11. LncRNA
Xu YJ; Zhao JM; Ni XF; Wang W; Hu WW; Wu CP
Epigenomics; 2021 Aug; 13(16):1281-1297. PubMed ID: 34523356
[TBL] [Abstract][Full Text] [Related]
12. The involvement and therapeutic potential of lncRNA Kcnq1ot1/miR-34a-5p/Sirt1 pathway in arsenic trioxide-induced cardiotoxicity.
Shen X; Zhi F; Shi C; Xu J; Chao Y; Xu J; Jiang Y; Bai Y; Yang B
J Transl Med; 2023 Jan; 21(1):52. PubMed ID: 36707890
[TBL] [Abstract][Full Text] [Related]
13. LINC00657 activates PD-L1 to promote osteosarcoma metastasis via miR-106a.
Zhang J; Chou X; Zhuang M; Zhu C; Hu Y; Cheng D; Liu Z
J Cell Biochem; 2020 Oct; 121(10):4188-4195. PubMed ID: 31898338
[TBL] [Abstract][Full Text] [Related]
14. KCNQ1OT1 polymorphism rs35622507 and methylation status of KCNQ1OT1 promoter influence the drug resistance to L-OHP.
Zhang C; Wang Y
Aging (Albany NY); 2022 Feb; 14(4):1836-1847. PubMed ID: 35193115
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Lnc-OC1 Induced Cell Apoptosis and Decreased Cell Viability by Releasing miR-34a and Inhibiting PD-L1 in Endometrial Carcinoma.
Liu Y; Chang Y; Cai YX
Reprod Sci; 2020 Oct; 27(10):1848-1856. PubMed ID: 32748220
[TBL] [Abstract][Full Text] [Related]
16. Yin Yang 1-stimulated long noncoding RNA bladder cancer-associated transcript 1 upregulation facilitates esophageal carcinoma progression via the microRNA-5590-3p/programmed cell death-ligand 1 pathway.
Cheng J; Yang Q; Han X; Wang H; Wu K; Zhao H
Bioengineered; 2022 Apr; 13(4):10244-10257. PubMed ID: 35435118
[TBL] [Abstract][Full Text] [Related]
17. LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760/PPP1R1B via the cAMP signalling pathway.
Xian D; Zhao Y
J Cell Mol Med; 2019 Jun; 23(6):3808-3823. PubMed ID: 30997746
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas.
Yoon CJ; Chang MS; Kim DH; Kim W; Koo BK; Yun SC; Kim SH; Kim YS; Woo JH
Gastric Cancer; 2020 Sep; 23(5):780-795. PubMed ID: 32206940
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA regulatory factor X3- antisense RNA 1 promotes non-small cell lung cancer via the microRNA-577/signal transducer and activator of transcription 3 axis.
Hu Y; Zhao Z; Jin G; Guo J; Nan F; Hu X; Hu Y; Han Q
Bioengineered; 2022 Apr; 13(4):10749-10764. PubMed ID: 35475457
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p.
Zhou WY; Zhang MM; Liu C; Kang Y; Wang JO; Yang XH
J Cell Physiol; 2019 Dec; 234(12):23176-23189. PubMed ID: 31206665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
